MARKER THERAPEUTICS, INC. (MRKR) Return on equity 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-72.4%FY2025 · since FY2017: -300.2% → -72.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.4% | -14.6 pp |
| FY2024 | -57.8% | +0.8 pp |
| FY2023 | -58.6% | +94.1 pp |
| FY2022 | -152.7% | -57.5 pp |
| FY2021 | -95.2% | +9.8 pp |
| FY2020 | -105.0% | -56.4 pp |
| FY2019 | -48.6% | +200.7 pp |
| FY2018 | -249.3% | +50.9 pp |
| FY2017 | -300.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Capital expendituresMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →